Trials that use: Covariate adjustment
5,848 results
- Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Smoking Cessation Intervention for Thoracic Patients: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Intervention for Thoracic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580398).
- Smoking Cessation Intervention in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Intervention in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03024606).
- Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation: Complete Statistical AnalysisIndependent statistical analysis of Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SMS TurkeyIndependent statistical analysis of SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SNIFFLE-3Independent statistical analysis of Efficacy & Safety of Nasal Influenza Immunisation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02549365).
- SOCIALIndependent statistical analysis of Supporting Our Caregivers In ADRD Learning (SOCIAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06276023).
- SOCRATESIndependent statistical analysis of [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration: Complete Statistical AnalysisIndependent statistical analysis of Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01923961).
- Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03752203).
- Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04824365).
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy: Complete Statistical AnalysisIndependent statistical analysis of Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy: primary endpoint results, effect…
- Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection: primary endpoint results,…
- SOFTIndependent statistical analysis of Bladder Drainage During Labor: A Randomized Controlled Study of Obstetric Foley Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SOLARIndependent statistical analysis of Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SOLEOIndependent statistical analysis of A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SOLO1Complete statistical analysis of SOLO1, a randomized phase 3 trial of olaparib maintenance monotherapy versus placebo in BRCA-mutated advanced ovarian cancer following first-line platinum-based chemotherapy.
- SOLO3Independent statistical analysis of Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received…
- SOLOIST-WHFIndependent statistical analysis of SOLOIST-WHF (NCT03521934), evaluating sotagliflozin versus placebo in participants with type 2 diabetes and worsening heart failure. Includes trial design, registered endpoints, Cox, ANCOVA and MMRM methodology, reported results,…
- SOM230Independent statistical analysis of Pasireotide LAR in Severe Polycystic Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01670110).
- Somatosensory Profiling in Radicular Pain Patients And it’s Correlation With Treatment Outcome: Complete Statistical AnalysisIndependent statistical analysis of Somatosensory Profiling in Radicular Pain Patients And it's Correlation With Treatment Outcome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SOMNOSIndependent statistical analysis of Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01503164).
- SONARIndependent statistical analysis of the phase 3 SONAR trial of atrasentan versus placebo in diabetic nephropathy, including the composite renal endpoint, hazard ratios, confidence intervals, p-values, trial design, and statistical methodology.
- Sonothrombolysis in Patients With STEMI: Complete Statistical AnalysisIndependent statistical analysis of Sonothrombolysis in Patients With STEMI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03092089).
- SOPRAIndependent statistical analysis of Selinexor (KPT-330) in Older Patients With Relapsed AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02088541).
- Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01510756).
- Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00126568).
- Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Soy Protein/Effexor Hormone Therapy for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Soy Protein/Effexor Hormone Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00354432).
- SPAFIndependent statistical analysis of Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPARCIndependent statistical analysis of Sustaining Patient-centered Alcohol-related Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02675777).
- SPARKIndependent statistical analysis of Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SPARKIndependent statistical analysis of Kuvan® in Phenylketonuria Patients Less Than 4 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01376908).
- SPARK2Independent statistical analysis of Phase 2B Study Assessing Pain Relief After Replacement of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPARTANIndependent statistical analysis of Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPARXIndependent statistical analysis of Study in Parkinson's Disease of Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01506479).
- Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion “Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma”: Complete Statistical AnalysisIndependent statistical analysis of Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma": primary endpoint results, effect estimate with confidence…
- Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01329380).
- Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Special Survey on Parkinson’s Disease (PD) Patients Without Concomitant Use of L-Dopa: Complete Statistical AnalysisIndependent statistical analysis of Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Specified Drug-Use Survey of Trelagliptin Tablets “Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease”: Complete Statistical AnalysisIndependent statistical analysis of Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease": primary endpoint results, effect…
- SPECSIndependent statistical analysis of SPECS: Safe Pediatric Euglycemia in Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00443599).
- Speech Locator In-car Performance Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Speech Locator In-car Performance Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05054816).
- Speech Processing in Stuttering: Complete Statistical AnalysisIndependent statistical analysis of Speech Processing in Stuttering: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04929184).